Gregory T. Went, Chief Executive Officer, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 2,728 shares at $18.00 ($49K) on 2015-05-14, disclosed to the SEC on 2015-05-14.
Scheduled sale ($49k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 1,800 | $32K | 66.0% |
| 2 | $18.01 | 500 | $9K | 18.3% |
| 3 | $18.00 | 28 | $504 | 1.0% |
| 4 | $18.00 | 100 | $2K | 3.7% |
| 5 | $18.00 | 100 | $2K | 3.7% |
| 6 | $18.00 | 200 |
| $4K |
| 7.3% |
| Total | $18.00 avg | 2,728 | $49K | 100% |
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-04-27 | $59K | — | Filing → |